Web26 mai 2024 · The panel will include an interactive discussion moderated by Jason McCarthy, Ph.D., Maxim Group Senior Managing Director, Biotechnology. Among the topics to be discussed are how cell therapy can ... WebJason McCarthy, Ph.D. Maxim Group LLC. Enveric Biosciences is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Enveric Biosciences’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Enveric Biosciences or its management.
Maxim ups Artelo Biosciences PT to $5 from $3 - BioTuesdays
Web26 mai 2024 · The panel will include an interactive discussion moderated by Jason McCarthy, Ph.D., Maxim Group Senior Managing Director, Biotechnology. WebAcum 7 ore · Maxim Group analyst Jason McCarthy downgrades Biocept (NASDAQ:BIOC) from Buy to Hold. ... Maxim Group Downgrades Biocept to Hold. by [email protected]. April 14, 2024 8:12 AM 18 seconds read. green mountain foods whitehall ny
Analyst Profile - BestBioInvestors
Web30 mar. 2024 · Bionano Genomics (BNGO) 2nd Annual Maxim Group Conference March 30, 2024, 3:30 PM ET. Seeking Alpha - Go to Homepage. Trending. ... Michael Okunewitch — Maxim Group. Jason McCarthy. WebLiked by Jason McCarthy, PhD. Great news! I am looking to expand our biotech equity research team at Maxim Group. As the Head of Biotech … Web17 dec. 2024 · Maxim Group initiated coverage of Cyclo Therapeutics (NASDAQ:CYTH) with a “buy” rating and $12 price target. The stock closed at $3.85 on Dec. 16. Cyclo is developing a Phase 3-ready hydroxypropyl beta cyclodextrin-based drug candidate, Trappsol Cyclo, to treat Niemann-Pick disease type C (NPC), a rare progressive genetic … green mountain food service whitehall ny